Answers are grounded in this paper and cite their sources.
Retrospective investigation reveals heightened mortality risks from concurrent arrhythmias in Kawasaki disease, highlighting the need for targeted cardiovascular surveillance.
Kawasaki disease (KD), a systemic vasculitis predominantly afflicting pediatric populations, manifests various cardiovascular sequelae. This retrospective investigation aimed to elucidate the potential linkage between arrhythmias and KD. Utilizing the NIS dataset spanning 2016 to 2020, a cohort encompassing 25,025 hospital admissions attributable to KD was scrutinized. Patients with concomitant arrhythmias, embracing atrioventricular block, ventricular tachycardia, ventricular fibrillation, and ventricular flutter were rigorously assessed alongside confounding variables, including heart failure, antecedent cardiac arrest, obesity, cardiomyopathy, and obstructive sleep apnea. Adjusted odds ratios were computed to ascertain the independent association of arrhythmias with adverse clinical outcomes. Among the cohort of KD admissions, 265 patients were identified with concurrent arrhythmias. The adjusted odds ratio for arrhythmias in KD patients stood at 2.212 (p < 0.001, CI 1.663 - 2.942), signifying a noteworthy association. Notably, patients exhibiting arrhythmias demonstrated significantly amplified odds of all-cause mortality (35.2, CI 3.513 - 352.664, p = 0.002). However, no statistically significant correlation was established between arrhythmias and cardiogenic shock (2.738, p = 0.389). Those afflicted with arrhythmias experienced aN increment of $214,226 in total charges (p = 0.055) and extended their average length of stay by 5.1 days (p = 0.046). Discussion: The findings underscore a robust association between the presence of arrhythmias in KD patients and adverse clinical trajectories, notably increased mortality. However, no substantive correlation was observed with cardiogenic shock. The discernible financial and clinical implications underscore the substantive burden associated with arrhythmias in this patient population. These empirical insights delineate the imperative significance of vigilant surveillance and targeted therapeutic strategies to mitigate the heightened risks and ameliorate the burdensome impact of arrhythmias on Kawasaki disease's clinical course and outcomes.
No takes yet. Share an insight, caveat, or question.
Sharu et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: